Neil E Hill1,2, Christopher Campbell1, Paul Buchanan3, Midge Knight3, Ian F Godsland4, Nick S Oliver1. 1. 1 Department of Diabetes & Endocrinology, Charing Cross Hospital, London, UK. 2. 2 Academic Department of Military Medicine, Royal Centre for Defence Medicine, Birmingham, UK. 3. 3 Team Blood Glucose, Nottingham, UK. 4. 4 Diabetes Endocrinology and Metabolic Medicine, Faculty of Medicine, Imperial College London, St. Mary's Campus, London, UK.
Abstract
BACKGROUND: Increasing numbers of people with diabetes are adopting exercise programs. Fear of hypoglycemia, hypoglycemia itself, and injuries are major issues for many people with diabetes undertaking physical activity. The purpose of this study was to investigate the effects of type 1 diabetes mellitus on the risk of hypoglycemia, glycemic variability, exercise performance, changes in body composition, changes in insulin dosage, and psychosocial well-being during a multiday endurance exercise event. METHODS: Eleven participants (7 with type 1 diabetes, 4 with normal glucose tolerance) undertook a 15-day, 2300 km cycling tour from Barcelona to Vienna. Data were prospectively collected using bike computers, continuous glucose monitors, body composition analyzers, and mood questionnaires. RESULTS: Mean blood glucose in riders with and without diabetes significantly reduced as the event progressed. Glycemic variability and time spent in hypoglycemia did not change throughout the ride for either set of riders. Riders with diabetes in the lowest quartile of sensor glucose values had significantly reduced power output. Percentage body fat also significantly fell. Hypo- and hyperglycemia provoked feelings of anxiety and worry. CONCLUSIONS: This is the first study to describe a real-time endurance event in type 1 diabetes, and provides important new data that cannot be studied in laboratory conditions. Hypoglycemia continues to occurs in spite of peer support and large reductions in insulin dose. Glycemic variability is shown as a potential barrier to participation in physical activity through effects on mood and psychological well-being.
BACKGROUND: Increasing numbers of people with diabetes are adopting exercise programs. Fear of hypoglycemia, hypoglycemia itself, and injuries are major issues for many people with diabetes undertaking physical activity. The purpose of this study was to investigate the effects of type 1 diabetes mellitus on the risk of hypoglycemia, glycemic variability, exercise performance, changes in body composition, changes in insulin dosage, and psychosocial well-being during a multiday endurance exercise event. METHODS: Eleven participants (7 with type 1 diabetes, 4 with normal glucose tolerance) undertook a 15-day, 2300 km cycling tour from Barcelona to Vienna. Data were prospectively collected using bike computers, continuous glucose monitors, body composition analyzers, and mood questionnaires. RESULTS: Mean blood glucose in riders with and without diabetes significantly reduced as the event progressed. Glycemic variability and time spent in hypoglycemia did not change throughout the ride for either set of riders. Riders with diabetes in the lowest quartile of sensor glucose values had significantly reduced power output. Percentage body fat also significantly fell. Hypo- and hyperglycemia provoked feelings of anxiety and worry. CONCLUSIONS: This is the first study to describe a real-time endurance event in type 1 diabetes, and provides important new data that cannot be studied in laboratory conditions. Hypoglycemia continues to occurs in spite of peer support and large reductions in insulin dose. Glycemic variability is shown as a potential barrier to participation in physical activity through effects on mood and psychological well-being.
Entities:
Keywords:
continuous glucose monitoring; endurance exercise; hypoglycemia; type 1 diabetes
Authors: Boris P Kovatchev; Daniel J Cox; Anand Kumar; Linda Gonder-Frederick; William L Clarke Journal: Diabetes Technol Ther Date: 2003 Impact factor: 6.118
Authors: J Kropff; D Bruttomesso; W Doll; A Farret; S Galasso; Y M Luijf; J K Mader; J Place; F Boscari; T R Pieber; E Renard; J H DeVries Journal: Diabetes Obes Metab Date: 2014-09-10 Impact factor: 6.577
Authors: Karen M Rothacker; Sam Armstrong; Grant J Smith; Nat Benjanuvatra; Brendan Lay; Peter Adolfsson; Timothy W Jones; Paul A Fournier; Elizabeth A Davis Journal: Diabetologia Date: 2021-05-04 Impact factor: 10.122
Authors: Olivia McCarthy; Max L Eckstein; Sam N Scott; Federico Y Fontana; Mark P Christiansen; Christoph Stettler; Miles Fisher; Bruce Bode; Michael C Riddell; Charlotte Hayes; Peter L Lagrou; Phil Southerland; Othmar Moser; Richard M Bracken Journal: BMJ Open Diabetes Res Care Date: 2020-04